| Quad Therapy |
|
|
|
|
Friday, 15 July 2011 18:16
|
|
A recent study using two new drugs, BMS-790052 and BMS-650032, combined with pegylated interferon and ribavirin achieved a 100% sustained virological response in people with chronic hepatitis C. The study involved previous non-responders with genotype 1. In addition, 11 people were treated only with the two new drugs (without pegylated interferon and ribavirin) and of these 4 achieved sustained virological response.
|